Summary: This Earth Month we at InVivo Biosystems are thinking about how we utilize Earth’s resources in biomedicine – from animal systems that enable us to model a patient’s disease or gene mutation, to natural products which can act as therapeutics, we have a lot to be grateful for. Often when thinking about celebrating Earth …
Quick Guide to Natural Products: What They are and How They Impact You Read More »
In this article, we will discuss the commonly used model organisms for microbiome research, and what insights they can provide.
Summary Zebrafish models largely began as a way to research developmental biology, however, their potential to be a preclinical model of human disease quickly became apparent. While the pharmaceutical industry initially invested in zebrafish models, they have yet to widely adopt it – it’s time for that to change. George Stresinger began using zebrafish as …
Lost and Found: Zebrafish as a Drug Discovery Tool Read More »
In this article we discuss Weissbourd’s recent publication as well as GCaMP more broadly, showing how advancing technology has enabled researchers to ask questions that span disciplines and model organism species.
Recently, researchers at Cleveland Clinic’s Genomic Medicine Institute published an article in Nature Aging which has caused quite a stir in the medical community and media – in the article these researchers report that an analysis of over 7 million people, spanning six years, found that those taking the Erectile dysfunction (ED) drug sildenafil (marketed as Viagra) were 69% less likely to develop Alzheimer’s disease (AD). This being said, there are some important caveats to this study – and so, although media reports on this study include lines such as “the little blue pill could soon be prescribed to tackle dementia”, more realistic implications should be the takeaway (but not less exciting!).
Experiments fall into three categories – in vivo, in vitro, and in silico studies, and all of them have a different, but important role in research. This article will give a brief definition of each category and an overview of their research applications.
Pharmaceutical drugs go through a rigorous process that tests their safety and efficacy before gaining FDA approval and being put on the commercial market. Traditionally, preclinical trials utilize mammalian models before clinical trials are performed (mammals are considered the gold standard of trials). But are these trials serving everyone? This article will discuss the pervasive inequality between the male and female sexes in drug development and what can be done about it.
In this article we will explore how the nutraceutical regulations compare in the USA and abroad, asking how they are defined in each country, what licensing is needed, how this affects manufacturers, and what this indicates for the future of the market.
We’ve rounded up some of the recent publications that we’ve been enjoying – click their links below to see what’s new in this space!
Thanks to InVivo Biosystems, Dr. Galyan now has the data necessary to present to investors to fund additional research into the compound. Additionally, he was able to use the data to submit a patent application on the compound in September of 2021.
